Crestor rosuvastatin: NDA submitted

AZN denied rumors that the FDA requested that the company start new trials of Crestor in order to gain approval of the cholesterol treatment. AZN said

Read the full 264 word article

How to gain access

Continue reading with a
two-week free trial.